Evidence map›Paper›PMID 23853579›Full record

ArticlePLoS pathogens2013

DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis.

Scarlet S Shell, Erin G Prestwich, Seung-Hun Baek, Rupal R Shah, Christopher M Sassetti, Peter C Dedon, Sarah M Fortune

Open access · goldAbstract readComparative Study
In one paragraph

Article in PLoS pathogens, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 172 citations in OpenAlex.

  1. mSystems · 2026
    Article
  2. Review
  3. Genome-wide transcriptional landscape ofFrontiers in immunology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Genomic Insight into Primary Adaptation ofAntibiotics (Basel, Switzerland) · 2025
    Article
  9. Review
  10. Epigenetic Mechanisms Induced byInternational journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways inbioRxiv : the preprint server for biology · 2024
    Article
  17. Review
  18. Article
  19. Heliyon · 2023
    Article
  20. The future of cancer immunotherapy: DNA vaccines leading the way.Medical oncology (Northwood, London, England) · 2023
    Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Scarlet S ShellDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Erin G Prestwich
Seung-Hun Baek
Rupal R Shah
Christopher M Sassetti
Peter C Dedon
Sarah M Fortune
Harvard University · USUniversity of Massachusetts Chan Medical School · USCenter for Environmental Health · USMassachusetts Institute of Technology · US

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 1985 to 2020
$25.6M
TRAINING GRANTS IN ENVIROMENTAL TOXICOLOGYT32ES007020 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESSIGMANN, JOHN M · 1985 to 2024
$13.1M
Tuberculosis Pathogenesis and Drug ResponseR01AI064282 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SASSETTI, CHRISTOPHER M · 2007 to 2017
$3.9M
Variation in M. tuberculosis in response to host selectionDP2OD001378 · OD · HARVARD SCHOOL OF PUBLIC HEALTH · PI FORTUNE, SARAH · 2007 to 2009
$2.5M
The regulatory function of DNA methylation in Mycobacterium tuberculosisF32AI085911 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI SHELL, SCARLET SARA · 2010 to 2012
$159k
Howard Hughes Medical InstituteNIAID NIH HHS 5F32AI085911-02NIAID NIH HHS AI064282NIAID NIH HHS F32 AI085911NIAID NIH HHS R01 AI064282NIEHS NIH HHS 5T32-ES007020-34NIEHS NIH HHS ES002109NIEHS NIH HHS P30 ES002109NIEHS NIH HHS T32 ES007020NIH HHS 1DP2OD001378-01NIH HHS DP2 OD001378
6 · The paper itself

Abstract

DNA methylation regulates gene expression in many organisms. In eukaryotes, DNA methylation is associated with gene repression, while it exerts both activating and repressive effects in the Proteobacteria through largely locus-specific mechanisms. Here, we identify a critical DNA methyltransferase in M. tuberculosis, which we term MamA. MamA creates N⁶-methyladenine in a six base pair recognition sequence present in approximately 2,000 copies on each strand of the genome. Loss of MamA reduces the expression of a number of genes. Each has a MamA site located at a conserved position relative to the sigma factor -10 binding site and transcriptional start site, suggesting that MamA modulates their expression through a shared, not locus-specific, mechanism. While strains lacking MamA grow normally in vitro, they are attenuated in hypoxic conditions, suggesting that methylation promotes survival in discrete host microenvironments. Interestingly, we demonstrate strikingly different patterns of DNA methyltransferase activity in different lineages of M. tuberculosis, which have been associated with preferences for distinct host environments and different disease courses in humans. Thus, MamA is the major functional adenine methyltransferase in M. tuberculosis strains of the Euro-American lineage while strains of the Beijing lineage harbor a point mutation that largely inactivates MamA but possess a second functional DNA methyltransferase. Our results indicate that MamA influences gene expression in M. tuberculosis and plays an important but strain-specific role in fitness during hypoxia.

Indexed as

DNA MethylationGene Expression Regulation, BacterialAnimalsBacterial LoadBacterial ProteinsCodon, InitiatorDNA, BacterialFemaleGene DeletionGene Expression ProfilingHumansIsoenzymesLungMiceMice, Inbred C57BLMicrobial ViabilityBacterial ProteinsCodon, InitiatorDNA, BacterialIsoenzymesSite-Specific DNA-Methyltransferase (Adenine-Specific)

Identifiers

PMID23853579
PMCPMC3701705
OpenAlexW2127766990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.